Synthace
London
About Synthace
Synthace is a digital experiment platform built for life science R&D teams to help them run more powerful experiments. It digitizes experiments from end to end: with minimal training, scientists can design and plan reproducible experiments, simulate them ahead of time, run them on their automation equipment, and automatically structure all of their experimental data and metadata in a single place. Controlled from a browser window and needing no code to operate, it makes experiments easier to run in the lab, increases the scientific value of experiments, and also makes it possible to run experiments that were previously thought impossible.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $81.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2021)
- Website: synthace.com
- Phone: +44 (0) 20 3976 7676
Industries & Categories
Biotechnology, Industrial Automation, Life Science, Pharmaceutical, Software
Social Profiles
Canonical: https://fsome.com/organization/synthace-72381 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.